Description
Seeking women whose endometrial cancer has previously been treated with platinum-based chemotherapy and immunotherapy for a study of an investigational drug.
Overview
Participants in this study will be randomly assigned to get either the investigational drug or the usual treatment. The drugs are given as an IV infusion every 2 weeks for the investigational drug or every 3-4 weeks for the usual treatment.
What we're hoping for
We are studying whether an investigational drug is better, worse, or the same as the usual treatment for endometrial cancer previously treated with platinum-based chemotherapy and immunotherapy.
Additional Information
ClinicalTrials.gov Identifier: NCT06132958